Chronic Renal Failure and Cardiovascular Disease: A Comprehensive Appraisal

Area of Science:

• Cardiology
• Nephrology
• Internal Medicine

Background:

• Coronary artery disease (CAD) is common in patients with chronic kidney disease (CKD).
• CKD complicates the diagnosis and treatment of CAD due to altered biomarker thresholds and limited clinical trial data.
• Evaluating myocardial ischemia in CKD patients presents unique challenges.

Purpose of the Study:

• To review current literature on the diagnosis, treatment, and prevention of CAD in patients with CKD.
• To address the diagnostic and therapeutic challenges posed by the interplay of CKD and CAD.
• To provide insights into managing CAD in both acute and chronic settings for CKD patients.

Main Methods:

• Comprehensive literature review of studies concerning CAD in CKD patients.
• Analysis of diagnostic modalities and their efficacy in the CKD population.
• Evaluation of existing treatment strategies and their safety and effectiveness in CKD.

Main Results:

• Diagnostic criteria and interpretation of cardiac biomarkers and noninvasive tests differ in CKD patients.
• Evidence for optimal medical and interventional treatment strategies in advanced CKD is limited.
• Patients with advanced CKD are often excluded from major clinical trials, impacting treatment guidelines.

Conclusions:

• Accurate diagnosis of CAD in CKD requires consideration of altered physiological parameters.
• Treatment decisions for CAD in CKD must balance potential benefits against safety concerns, especially in advanced stages.
• Further research is needed to establish evidence-based guidelines for CAD management in CKD patients.